NCT01797874View on ClinicalTrials.gov

Pazopanib Maintenance for SCLC

PHASE2CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

December 31, 2017

Conditions
SCLC
Interventions
DRUG

Pazopanib

Experimental

DRUG

Placebo

placebo arm

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT01797874 - Pazopanib Maintenance for SCLC | Biotech Hunter | Biotech Hunter